Stockreport

Allurion Technologies: Study Results Cause Rally, But I'm Awaiting 2024 FDA Catalyst [Seeking Alpha]

Allurion Technologies, Inc.  (ALUR) 
PDF The company currently sells the balloon to Europe, but US potential is still limited by awaiting FDA approval anticipated in late 2024. FDA approval is Allurion's major [Read more]